Access Recognized for Second Consecutive Year in Inc.’s Annual Power Partner Awards
25 oct. 2023 09h00 HE
|
Access Information Management Shared Services, LLC
Roundup highlights B2B partners that support startups across all business functions and empower growth for their clients.
Intetics Is Recognized as Inc. 2023 Power Partner Awards Honoree in the AI & Data Category
25 oct. 2023 06h01 HE
|
Intetics Inc.
Inc. named Intetics an honoree on the 2023 Power Partner Awards list in the Artificial Intelligence & Data category.
MarginEdge Recognized by Inc.’s Power Partner Awards and Washington Business Journal’s Fastest Growing Companies 2023
24 oct. 2023 08h00 HE
|
MarginEdge
ARLINGTON, Va., Oct. 24, 2023 (GLOBE NEWSWIRE) -- MarginEdge, the leading restaurant management and bill payment platform, today announced it has been recognized by the 2023 Inc. Power Partners...
Text Request Honored with Inc. Power Partner Award for 2nd Year
24 oct. 2023 07h33 HE
|
Text Request
CHATTANOOGA, TENN., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Text Request, the industry-leading business messaging platform, has been recognized as an Inc. Power Partner for the second year in a row....
Novartis Pluvicto™ shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer in the pre-taxane setting
23 oct. 2023 10h30 HE
|
Novartis Pharma AG
Phase III PSMAfore trial with Pluvicto™ met its primary endpoint of radiographic progression-free survival (rPFS) with a HR of 0.411; Pluvicto more than doubled median rPFS to 12.0 months per updated...
Novartis radioligand therapy Lutathera® demonstrated statistically significant and clinically meaningful progression-free survival in first line advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
25 sept. 2023 01h17 HE
|
Novartis Pharma AG
Phase III NETTER-2 trial met primary endpoint of improvement in progression-free survival (PFS) and key secondary endpoint of objective response rate (ORR) in patients with Grade 2 and 3 advanced...
Barrack, Rodos & Bacine Investigates Napco Security Technologies, Inc. (NSSC)
24 août 2023 09h30 HE
|
Barrack Rodos & Bacine
PHILADELPHIA, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine (BR&B) is investigating Napco Security Technologies, Inc. (“Napco”) (NASDAQ: NSSC) for potential violations of federal...
NCSBN Selects Philip Dickison as New CEO
23 mai 2023 10h24 HE
|
NCSBN
Chicago, May 23, 2023 (GLOBE NEWSWIRE) -- Today, The National Council of State Boards of Nursing (NCSBN®) Board of Directors (BOD), has named Philip Dickison, PhD, RN, to succeed retiring CEO David...
EQUITY ALERT: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Edgio, Inc. f/k/a Limelight Networks, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EGIO, LLNW
27 avr. 2023 12h23 HE
|
The Rosen Law Firm PA
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edgio,...
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
04 avr. 2023 17h15 HE
|
The Rosen Law Firm PA
NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Phathom...